From Hypothesis to Breakthrough: Meta‑Flux Secures €1.8M to Shrink Drug Discovery Timelines
A Dublin‑based biotech startup, Meta‑Flux, has secured €1.8 million ($2 million) in seed funding to accelerate its AI‑powered decision support platform designed for drug discovery. The company helps scientists navigate complex biological data to identify biomarkers and disease subtypes faster—compressing timelines from years to just weeks. Unlike black-box AI tools, Meta‑Flux blends multi‑omic, clinical, and…
